Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants

被引：0
|
作者：
Li, Xiao [1 ]
Bilcke, Joke [1 ]
Beutels, Philippe [1 ]
机构：
[1] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis CHERMID, Campus Drie Eiken,Univ Pl 1, B-2610 Antwerp, Belgium
来源：
LANCET REGIONAL HEALTH-AMERICAS | 2024年 / 29卷
关键词：
D O I：
10.1016/j.lana.2023.100657
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A COST-EFFECTIVENESS ANALYSIS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN INFANTS IN THE UK
    Bentley, A.
    Filipovic, I.
    Gooch, K.
    Buesch, K.
    THORAX, 2011, 66 : A136 - A137
  • [2] Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina
    Guinazu, Gonzalo
    Dvorkin, Julia
    Mahmud, Sarwat
    Baral, Ranju
    Pecenka, Clint
    Libster, Romina
    Clark, Andrew
    Caballero, Mauricio T.
    VACCINE, 2024, 42 (23)
  • [3] Cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis among preterm infants in Poland
    Kowalik, E
    Jakubczyk, MK
    Niewada, MP
    Kamiñski, B
    VALUE IN HEALTH, 2003, 6 (06) : 758 - 759
  • [4] A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
    Bentley A.
    Filipovic I.
    Gooch K.
    Büsch K.
    Health Economics Review, 3 (1) : 1 - 12
  • [5] COST-EFFECTIVENESS OF PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV) WITH PALIVIZUMAB IN PRETERM INFANTS IN COLOMBIA
    Rosselli, D.
    Rueda, J. D.
    Ruiz, J. G.
    VALUE IN HEALTH, 2013, 16 (03) : A75 - A75
  • [6] COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREVENTION INTERVENTIONS IN CHILDREN: A MODEL COMPARISON STUDY
    Li, X. X.
    Hodgson, D.
    Flaig, J.
    Kieffer, A.
    Herring, W.
    Beyhaghi, H.
    Williem, L.
    Jit, M.
    Bilcke, J.
    Beutels, P.
    VALUE IN HEALTH, 2022, 25 (12) : S178 - S178
  • [7] COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION OF DUTCH ELDERLY
    Pouwels, K.
    Meijboom, M.
    Luytjes, W.
    Hak, E.
    Postma, M.
    VALUE IN HEALTH, 2011, 14 (07) : A271 - A271
  • [8] COST-EFFECTIVENESS OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG US INFANTS EXPERIENCING THEIR FIRST RSV SEASON
    Beuvelet, M.
    Chung-Delgado, K.
    Kieffer, A.
    VALUE IN HEALTH, 2021, 24 : S110 - S110
  • [9] BURDEN OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND POTENTIAL IMPACT OF PROPHYLAXIS IN INFANTS IN SWEDEN: A COST-EFFECTIVENESS ANALYSIS
    Neovius, K.
    Buesch, K.
    Neovius, M.
    ACTA PAEDIATRICA, 2010, 99 : 96 - 97
  • [10] Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
    Ishiwada, Naruhiko
    Akaishi, Rina
    Kobayashi, Yasuhiro
    Togo, Kanae
    Yonemoto, Naohiro
    Matsuo, Moe
    Kaneko, Shinnosuke
    Law, Amy W.
    Kamei, Kazumasa
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (07) : 1665 - 1682
12345